Since Vice President Kamala Harris entered the presidential race, she and former President Donald Trump have sparred over ...

CMS must develop and share publicly a clear evidence synthesis process that it will follow in future rounds of the Medicare ...

The IQVIA analysis finds that the impact of drug price negotiation on patients’ out-of-pocket spending could also be smaller ...

Lower drug prices are likely to result in more costs being shifted to working Americans. New versions of drugs and compounds ...

"Donald Trump said he was going to allow Medicare to negotiate drug prices. He never did. We did," Kamala Harris said during ...

On “The View,” Kamala Harris announced a plan to fund home care under Medicare by cutting into the pharmaceutical industry’s ...

Potential new benefit for home health care for seniors to be funded through Medicare drug price negotiations, likely ...

Guidance for the second cycle of Medicare drug price negotiations has expectations high for significant savings by 2026.

Now that the first round of price negotiations is complete, CMS' new guidelines will provide more time for drugmakers to make ...

The Centers for Medicare & Medicaid Services (CMS) rolled out guidance Oct. 2 as stakeholders prep for the second round of ...

The adjusted guidelines will provide drugmakers with more opportunities to engage with the Centers for Medicare and Medicaid ...

The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.